Old Web
English
Sign In
Acemap
>
Paper
>
PATIENT PHENOTYPES AND SGLT-2 INHIBITION IN TYPE 2 DIABETES MELLITUS: INSIGHTS FROM THE EMPA-REG OUTCOME TRIAL
PATIENT PHENOTYPES AND SGLT-2 INHIBITION IN TYPE 2 DIABETES MELLITUS: INSIGHTS FROM THE EMPA-REG OUTCOME TRIAL
2020
Abhinav Sharma
A. Ofstad
T. Ahmad
B. Zinman
Isabella Zwiener
David Fitchett
C. Wanner
J. George
Stefan Hantel
N Desai
Robert J. Mentz
Keywords:
Oncology
Internal medicine
Type 2 Diabetes Mellitus
EMPA
Phenotype
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]